“FDA Approved Empagliflozin for Adults with Chronic Kidney Disease at Risk of Progression”

Authors

Katherine Tuttle, ProvidenceFollow

Document Type

News Article

Publication Date

8-1-2023

Keywords

washington; spokane; prmc

Clinical Institute

Kidney & Diabetes

Specialty

Endocrinology

Specialty

Nephrology

Comments

Pharmacy Times

Recommended Citation

Tuttle, Katherine, "“FDA Approved Empagliflozin for Adults with Chronic Kidney Disease at Risk of Progression”" (2023). Articles, Abstracts, and Reports. 8247.
https://digitalcommons.providence.org/publications/8247